株式会社オージャスト (Headquarters: Osaka, CEO: Kim Kong-yong) officially launched 'Gakkai Kyosan Navi' (https://sponsor.gakkaisupport.jp/) on Thursday, May 21, 2026, a matching platform that connects medical societies and research groups nationwide with companies considering sponsorship.
'Gakkai Kyosan Navi' - One of Japan's Largest Medical Society Sponsorship Matching Platforms
Medical society operations have long depended on sponsorship from pharmaceutical and medical device manufacturers. However, due to stricter transparency guidelines and industry restructuring, such 'in-industry sponsorship' is gradually declining, affecting the development of medicine itself through smaller academic conferences and reduced funding for young researchers.
This service aims to bridge research and society by broadening the base of sponsorship funding for medical societies. It provides a mechanism for companies outside the medical industry, which previously had few touchpoints with medical societies, to discover appropriate sponsorship opportunities.
Background: Changes in the Sponsorship Environment for Medical Societies
There are over 6,000 large and small medical societies and research groups in Japan, directly supporting the development of medicine as venues for knowledge sharing, research presentation, and the cultivation of young researchers.
However, most of their operating costs have long relied on sponsorships from pharmaceutical and medical device companies. In recent years, against the backdrop of tightened transparency guidelines, stricter compliance standards, and reviews of marketing budgets due to industry restructuring, these traditional sponsorships have been declining step-by-step.
As a result, societies are expressing concerns such as: - Considering downsizing or holding academic conferences every other year - Reductions in incentives for young researchers' presentations and travel grants - The permanent state of compensating for deficits in secretariat operating costs - Decreases in opportunities for research presentations and stagnation in human resource development
While these may seem like 'internal society matters,' they are important issues that impact the long-term competitiveness of Japanese medical research.
Direction of Solution: Broadening the Sponsorship Base Beyond the Medical Industry
株式会社オージャスト has supported companies outside the medical industry—such as IT, human resources, insurance, manufacturing, food, and retail—and health-tech ventures in sponsoring medical societies to reach medical professionals. In doing so, they noticed the following facts:
- Corporate Side: Many cross-industry companies want to approach high-purchasing-power, high-expertise physicians and medical professionals, but it is difficult to find societies that accept them, and there is no way to know which societies align with their business areas. - Society Side: More secretariats welcome sponsorship from outside the industry, but they lack contact methods, making it difficult to open their doors to non-traditional partners.
By structurally resolving this mismatch, the total amount of sponsorship funding for societies can be boosted—this is the origin of the launch of 'Gakkai Kyosan Navi.'
'Gakkai Kyosan Navi' Service Overview
- Service Name: Gakkai Kyosan Navi - URL: https://sponsor.gakkaisupport.jp/ - Launch Date: Thursday, May 21, 2026 - Number of Societies Listed: Over 6,000 nationwide - Target Companies: Any corporation considering sponsorship of medical professionals/societies - Usage Fees: Initial fees for search, registration, and referrals are free (separate success-based commission applies)
Main Features - Medical Society Database Search: Search by field, region, timing, scale, and format. - Member Function (Free): View detailed information including visitor demographics, physician ratio, booth unit price range, and application deadlines. - Sponsorship Referral Support: Proxy services for contact with society secretariats. - Free Listing for Secretariats: Requests for listing or revisions handled within 48 hours.
Our Mission
The foundation supporting the development of medicine is the realistic base of 'budget.' Broadening the base of sponsoring companies protects opportunities for young researchers to present and leads to improved quality of medicine. As a neutral platform, we will cultivate a system that supports the development of medicine by society as a whole.
FACT BOX
- Source: PR TIMES
- Category: New Product